Ardea Biosciences, Inc. (RDEA) Monday released the financial results for the first quarter ended 31 March 2012, reporting a net loss of $40.9 million or $1.25 per share, wider than a net loss of $15.20 million or $0.59 per share reported for the same quarter last year.
The company attributed the wider loss primarily to lower revenue and fluctuations in operating expenses.
Total revenues for the quarter declined to $1.5 million from $1.8 million reported for the corresponding quarter last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.